Shahab Fatheazam

Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA.

Lincoln International LLC provides investment banking services. It specializes in strategic advisory services including sell-side mergers and acquisitions, buy-side mergers and acquisitions, debt advisory, growth equity, special situations, valuations and opinions and pensions advisory services. The firm offers capital raising, mergers and acquisitions support, and other corporate finance services. It provides their clients with industry knowledge and access to a comprehensive range of buyers, sellers, and investors. The company was founded in 1996 by Lawrence J. Lawson and is headquartered in Chicago, IL.

Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania.

Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999.

Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.